Beta Finch - S&P 100 - EN

More earnings analysis: https://betafinch.com
Groups: MAG7 (https://betafinch.com/groups/MAG7)
──────────
WELCOME TO BETA FINCH: TESLA Q2 2026 EARNINGS BREAKDOWN

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're diving into Tesla's Q2 2026 results. Big call, lots of Elon energy, so let's get into it. But first, the standard reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, glad that's out of the way, because there's a lot to unpack here. Tesla posted record Q2 deliveries, and CFO Vaibhav Taneja said they exited the quarter with their largest order backlog since 2023.

ALEX: Right, and the growth wasn't even — Americas deliveries up 60% sequentially, APAC up 27%, EMEA up 12%. Model Y is setting records in markets like the Netherlands, Australia, New Zealand.

JORDAN: But here's the thing investors need to sit with — margins told a different story. Automotive gross margin, excluding regulatory credits, fell from 19.2% to 16.3% quarter over quarter.

ALEX: And a chunk of that is a comp issue, not a fresh problem, right? Q1 had a one-time $230 million benefit from warranty true-downs and tariff relief that just didn't repeat.

JORDAN: Exactly, strip that out and margins were roughly flat. Still, rising interest rates are pinching them too — subvention costs get booked upfront as a revenue offset, so as rates climbed this year, that ate into margin as well.

ALEX: Energy storage is the other margin story. They deployed 13.5 gigawatt-hours, up 53% sequentially, second-best quarter ever for that business. But gross margin there dropped hard, from 39.5% down to 20.4%.

JORDAN: A $240 million warranty true-up on legacy battery cells, tariff benefits rolling off, and ASPs coming down as competition heats up in industrial storage. Vaibhav said long-term they expect that business to normalize in the mid-to-low 20% margin range, so this quarter isn't really the new normal, it's a rough patch.

ALEX: One bright spot — service and other margins hit an all-time high, 14.1%, up from 9.2%. Better fleet cost management, plus some early Robotaxi infrastructure spend baked in there.

JORDAN: Now the number that's going to dominate headlines — CapEx more than doubled sequentially, and free cash flow went negative for the quarter, as they'd guided. Full-year CapEx guide is now more than $25 billion, and it's expected to keep climbing for two to three more years.

ALEX: They're even lining up debt facilities, up to $30 billion in borrowing capacity, to help fund it. This is genuinely one of the biggest industrial buildouts in company history — Elon literally compared the scale to Henry Ford's Model T ramp or wartime production mobilization.

JORDAN: Which brings us to the strategy side, because the story here isn't really about car margins this quarter — it's about what all that CapEx is buying. Optimus, Robotaxi, the new chip fab they're calling Terafab, solar manufacturing, battery and lithium refining. It's an enormous number of S-curves being started at once.

ALEX: Let's talk Robotaxi, because Ashok, their VP of AI, gave a genuinely striking safety stat — over 380,000 unsupervised miles across six cities, zero notable incidents.

JORDAN: That's the headline number, and it's meant to counter the argument that you need lidar and HD maps to do this safely. Tesla's whole pitch is cameras-only can work. What I'd flag for listeners is the scale is still small — Colin from Wells Fargo pushed on this, noting the actual vehicle counts look like dozens, not hundreds, despite the city expansion.

ALEX: And the answer was basically: these cars run near-continuously, so miles accumulate fast even with a small fleet, plus they want to prove the software generalizes

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: MAG7 (https://betafinch.com/groups/MAG7)
──────────
**BETA FINCH PODCAST SCRIPT**

---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Tesla's Q4 2025 earnings call, and folks, this was quite a ride.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, where do we even begin with this call? Elon Musk literally opened by changing Tesla's mission statement to "amazing abundance" and talked about universal high income for everyone.

ALEX: Right? And then immediately pivoted to announcing they're killing off the Model S and X next quarter. Jordan, let's start with the numbers because there's a lot to unpack here.

JORDAN: The financial picture was actually pretty solid despite some challenges. Tesla hit record gross margins at 20.1% - something they haven't achieved in over two years. Automotive margins excluding credits improved sequentially from 15.4% to 17.9%, which is impressive given they had 16% lower deliveries in the quarter.

ALEX: That margin improvement despite lower volumes tells us a lot about their operational efficiency, doesn't it?

JORDAN: Exactly. CFO Vaibhav Taneja explained this was largely due to regional mix - they had proportionally more deliveries in Asia-Pacific and EMEA markets. But here's the kicker - they ended 2025 with a bigger backlog than in recent years, and none of those countries even have the latest FSD version yet.

ALEX: Speaking of FSD, the Full Self-Driving adoption numbers were interesting. They hit nearly 1.1 million paid customers globally, with 70% being upfront purchases. But they're transitioning to a subscription-only model going forward.

JORDAN: That subscription pivot is huge, Alex. It's going to impact automotive margins in the short term, but it sets them up for recurring revenue. Think Netflix for cars, but instead of entertainment, you're getting autonomous driving.

ALEX: And on the autonomy front, they're already running fully unsupervised robotaxis in Austin - no safety monitor, no chase car, just empty cars picking up paying customers.

JORDAN: The robotaxi deployment is scaling fast too. Musk said they're "well over 500" vehicles carrying paid customers between Bay Area and Austin, and he expects that to "double every month." Those are some aggressive scaling projections.

ALEX: Now let's talk about the elephant in the room - that massive CapEx guidance. They're projecting over $20 billion in capital expenditures for 2026, more than double their previous guidance of $9 billion.

JORDAN: This is where it gets wild, Alex. They're building six new factories simultaneously - refinery, LFP factories, CyberCab, Semi, a new mega factory, and that Optimus factory. Plus massive investments in AI compute infrastructure.

ALEX: The Optimus story is fascinating. They're literally converting the Model S and X production space in Fremont into a million-unit-per-year robot factory. Musk said Optimus 3 is so human-like that people could easily mistake it for a person.

JORDAN: And he's not just talking small numbers here. Long-term, he expects to make "far more CyberCabs than all other vehicles combined" because 90% of miles driven are with one or two passengers. They're essentially redesigning transportation around autonomous two-seaters.

ALEX: The CyberCab production starts in April, by the way. No steering wheel, no pedals - it's fully autonomous or it doesn't work. That's a bold statement about their confidence in the technology.

JORDAN: But here's what really caught my attention - Musk spending his Saturdays designing the AI5 chip. When the CEO is personally involved in ch

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into T-Mobile's second quarter 2026 results, and Jordan, this one's got a lot of moving pieces.

JORDAN: It really does, Alex. But before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, thanks Jordan. Okay, let's set the scene. T-Mobile's CEO Srini Gopalan came out swinging, calling this "another extraordinary quarter." And honestly, the numbers back that up. Postpaid service revenue up 13% year-over-year, total service revenue up 9%, core adjusted EBITDA up 12%. Those are big numbers for a company this size.

JORDAN: And the headline stat that jumped out at me was their Net Promoter Score — 46, which they're calling the highest NPS in wireless history among the big three carriers. That's not just a vanity metric either, because it's translating directly into subscriber growth. They added 277,000 postpaid accounts in Q2.

ALEX: Let's talk guidance, because CFO Peter Osvaldik gave a lot of detail here. Full-year service revenue guide stays around $77 billion, that's 8% growth. Core adjusted EBITDA guided between $37.1 and $37.5 billion, roughly 10% growth. And here's a nice surprise for shareholders — they actually raised free cash flow guidance to $18.4 to $18.8 billion, up $200 million at the midpoint, mostly thanks to lower cash taxes.

JORDAN: What I found interesting is the postpaid ARPA story. Headline growth was 2%, which sounds a little soft compared to that 13% service revenue number. But Osvaldik explained that's a comp issue — last year's UScellular acquisition and the fiber joint venture brought in lower-ARPA customers. Strip out the M&A noise and ARPA actually grew 3.7% year-over-year. By the end of the call, he even said they're now tracking toward the higher end of their 2.5-to-3% full-year ARPA guidance.

ALEX: That's a good example of why you have to listen past the top-line number. Now, one thing investors should flag for Q3 — they're expecting postpaid net account additions to drop to around 250,000, way down from the pace we've seen.

JORDAN: Right, and management was upfront about why. They're doing a rate plan modernization in Q3 that's expected to temporarily bump up account churn — but they specifically noted it's concentrated in accounts with fewer lines, so phone churn impact should be much smaller. It's a deliberate, planned dip, not a demand problem. Speaking of churn, actually, postpaid phone churn came in at just 0.85% this quarter, down meaningfully year-over-year.

ALEX: Let's get into the strategic stuff, because there was a lot here. Fixed wireless broadband continues to be a huge growth engine — they call it "5G broadband" now — and they're running under what they call a "fallow capacity model," basically only selling broadband capacity that would otherwise go unused on the network.

JORDAN: And they got a great question on this from an analyst worried that FWA is eating up too much network capacity. CTO John Saw pushed back pretty firmly, saying capacity is still several multiples of what they're actually using, and that AI traffic — which everyone's worried about — hasn't materially hit mobile networks yet because most AI workloads live in wireline data centers, not on phones.

ALEX: They also reiterated their target of 15 million fixed wireless customers by 2030, and interestingly said that number doesn't even include upside from new spectrum they're eyeing — C-Band 2.0 and 2.7 gigahertz, which could become available in 2027 and 2028.

JORDAN: That spectrum conversation was a big theme throughout the Q&A. Management was clearly excited but also cagey on specifics — Srini compared this moment to their earlier bet on 5G

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the latest insights from corporate America's quarterly results. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q1 2026 earnings call, and folks, this was quite a performance from the Un-carrier.

Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, T-Mobile really came out swinging this quarter. Let's start with the headline numbers because they're pretty impressive. Service revenue grew 11% year-over-year - that's four times faster than their closest competitor. But what really caught my eye was their customer satisfaction score, or NPS, hitting 45 - that's over 20% higher than their nearest rival.

**ALEX**: That NPS number is huge, Jordan. It really speaks to their strategy of providing "best network, best value, and best experience" all in one package. CEO Srinivasan Gopalan kept hammering this point that customers don't need to make trade-offs anymore with T-Mobile. And the numbers back it up - they added 217,000 postpaid net accounts, up 6% year-over-year, while also growing their average revenue per account by 3.9%.

**JORDAN**: Exactly. That's the holy grail - growing both customer volume AND revenue per customer. Speaking of growth, their broadband business continues to be a monster. They added over 500,000 broadband customers this quarter and called themselves "the fastest-growing ISP in America" yet again. They're targeting 15 million broadband customers by 2030, and here's the kicker - that projection assumes they don't buy any more spectrum and doesn't factor in 6G improvements.

**ALEX**: The broadband story is fascinating because they're using what they call "fallow capacity" on their 5G network. Essentially, they've built this massive network infrastructure, and during off-peak times, they can sell that unused capacity as home internet service. It's brilliant from a capital efficiency standpoint.

But Jordan, I think the most intriguing part of this call was their discussion about AI and what they're calling "physical AI." They announced a partnership with Figure AI to connect humanoid robots to their 5G Advanced network.

**JORDAN**: This is where things get really futuristic, Alex. T-Mobile is positioning itself at the intersection of AI and connectivity. They talked about building AI capabilities directly into their network core, and they're already beta-testing something called "Live Translation" that can translate your voice into 80 different languages in real-time. But the physical AI angle is what has me excited - they see a world where their network becomes the backbone for robotics and automation.

**ALEX**: The key insight from network chief John Saw was that T-Mobile built their 5G Advanced network specifically with this future in mind. They have innovations like uplink transmit switching and higher transmit power that give them advantages for these AI applications. It's not just about faster phones - they're thinking about robots, autonomous systems, and edge computing.

**JORDAN**: And that brings us to their guidance updates. CFO Peter Osvaldik raised several key metrics. They're now expecting 950,000 to 1.05 million total postpaid net account additions for the full year, up from previous guidance. Core adjusted EBITDA guidance went up by $100 million at the low end to $37.1-37.5 billion. Free cash flow guidance also increased by $100 million to $18.1-18.7 billion.

**ALEX**: Those guidance raises show real confidence in the business momentum. But what really caught investors' attention was the announcement that they're increasing

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q4 2025 earnings call, which was quite the spectacle - they held it as a special event halfway through their capital markets day cycle.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a call this was! New CEO Srini Gopalan really came out swinging, didn't he? Let's start with the headline numbers because they were impressive across the board.

**ALEX:** Absolutely. T-Mobile delivered 261,000 postpaid net account additions in Q4 - and here's the kicker, Jordan - that's 10 times what their nearest competitor who reports this metric delivered. They're not just winning, they're dominating.

**JORDAN:** That account growth is driving real value creation too. They posted 2.7% year-over-year growth in postpaid ARPA - that's Average Revenue Per Account, which is becoming their key metric going forward. More on that shift in a moment. But this translated to service revenue up 10% year-over-year on a reported basis, 5% organically.

**ALEX:** And here's what I love - they converted 25% of that service revenue into free cash flow for the full year. That's an industry-leading conversion rate that really shows the structural advantages of their business model.

**JORDAN:** Now, one of the biggest announcements was their guidance raise. They're now expecting about $77 billion in service revenue for 2026 - that's 8% growth including M&A, or 6% organic growth, which is actually an acceleration from 2025. For 2027, they're guiding to $80.5-81.5 billion, representing 5% growth with about 5% organic.

**ALEX:** What's driving this confidence? Well, Gopalan spent a lot of time talking about T-Mobile's "widening differentiation" - they claim to offer the best network, best value, and best experience with no trade-offs. And the proof is in their Net Promoter Score, which has really opened up a gap versus competitors over the last three years.

**JORDAN:** That NPS story is compelling, Alex. They showed this chart where back in 2023, they were basically neck-and-neck with competitors, but now they've clearly broken away from the pack. And network perception is shifting too - 26% of network switchers now see T-Mobile as having the best network, up from just 12.5% in 2020.

**ALEX:** Speaking of networks, they made some bold claims about being the undisputed 5G leader and even introduced live translation built directly into their network core using AI. Pretty cool stuff, though we should note they love to talk about being first to market with various technologies.

**JORDAN:** The broadband story is getting more interesting too. They raised their target to 15 million FWA customers by 2030, up from 12 million previously, plus they expect 3-4 million fiber customers. That would give them 18-19 million total broadband customers by 2030 - essentially building a massive business from scratch in just seven years.

**ALEX:** Now here's a significant change that caught my attention - they're dropping subscriber-level reporting and focusing exclusively on postpaid accounts and ARPA going forward. CFO Peter Osvaldik said this better aligns with how customers actually buy - as families and businesses, not individual lines.

**JORDAN:** That's a strategic shift that makes sense when you think about it. Over 90% of their postpaid lines are on multi-line accounts anyway. But it also means we'll have less granular data to work with as analysts and investors.

**ALEX:** Let's talk about capital allocation because this was a big th

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**Beta Finch: Thermo Fisher Scientific (TMO) Q2 2026 Earnings Breakdown**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Thermo Fisher Scientific's second quarter 2026 results, and Jordan, this is a genuinely strong print to sink our teeth into.

JORDAN: Before we get into it, quick disclaimer for everyone listening. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, with that out of the way, let's talk numbers. Thermo Fisher posted revenue of $11.99 billion, up 10% year-over-year. Adjusted operating income jumped 15% to $2.73 billion, and adjusted EPS grew 13% to $6.03 a share.

JORDAN: And what jumps out to me is that this wasn't a "beat on cost-cutting" quarter — this was a genuine top-line story. Organic revenue growth came in at 5%, which management explicitly said was about 2 points ahead of their own prior guidance. Margins expanded too — adjusted operating margin hit 22.8%, up 90 basis points. That's the kind of quarter where basically everything worked at once.

ALEX: Let's break down where that growth came from. All four end markets grew mid-single-digits or better. Pharma and biotech — their biggest bucket at roughly 60% of revenue — grew mid-single digits, led by bioproduction and clinical research. Industrial and applied also grew mid-single digits, diagnostics and healthcare grew mid-single digits, and even academic and government, which has been the soft spot for a while, returned to growth, albeit low single digits.

JORDAN: That academic and government comeback is worth sitting with for a second. CEO Marc Casper was careful not to declare victory there — he said they want to see it "more broad-based" before calling it a real trend. But the U.S. turned slightly positive, Europe was actually quite strong, and interestingly China stayed muted in that segment specifically. So it's a cautious green shoot, not a full recovery.

ALEX: Speaking of China — it's about 7.5% of total revenue and grew low single digits, which is its first return to growth in a while. Casper credited that to pharma/biotech and industrial and applied demand, while academic spending there remains flat. He was clear it's not yet accretive to overall company growth, but the trajectory is improving.

JORDAN: Now let's talk capital moves, because there's a lot going on here. Thermo Fisher closed the Clario acquisition in late March — that's digital clinical trial endpoint data — and it had a strong first full quarter of ownership. They also closed the filtration and separation business, formerly part of 3M/Solventum, which is showing strong demand and they're actually adding capacity.

ALEX: And on the flip side, they're divesting their microbiology business, expected to close in Q3. That business did about $645 million in revenue in 2025. They used the anticipated proceeds to fund a $1 billion share buyback in the quarter — so essentially pre-funding the repurchase ahead of the deal closing.

JORDAN: That divestiture does create some near-term drag, worth flagging for anyone modeling this out — management said it reduces 2026 revenue by about $200 million net of retained channel sales, and dings adjusted EPS by about $0.05 this year, growing to roughly $0.15 dilutive in the first full year after close.

ALEX: Which makes the guidance raise even more impressive, because it absorbs that headwind and still goes up. New revenue guidance is $47.4 to $48.1 billion, representing 6-8% reported growth. Organic growth guidance moved to "about 4%" for the full year — they kept the 3-4% range but said they now expect to land at the top of it. Adjusted EPS guidance rose to $24.93 to $2

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**BETA FINCH PODCAST SCRIPT**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Thermo Fisher Scientific's Q1 2026 earnings, and let me tell you, this one's got some interesting moving parts.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, TMO just reported their first quarter results, and on the surface, it looks like a pretty solid performance. What caught your attention first?

ALEX: Well, the headline numbers are decent but not spectacular. Revenue grew 6% to $11.01 billion, and adjusted EPS came in at $5.44, also up 6%. But here's the kicker - they actually beat their own guidance by 14 cents per share on the earnings side.

JORDAN: That's a nice beat. And they're raising full-year guidance too, right? New revenue range of $47.3 to $48.1 billion, up from the previous $46.3 to $47.2 billion range.

ALEX: Exactly. And on earnings, they're now expecting $24.64 to $25.12 per share, up from their original $24.22 to $24.80 guide. That represents 8% to 10% growth for the year. But Jordan, there's a big asterisk here - a lot of this guidance raise comes from their massive Clario acquisition.

JORDAN: Right, the $9 billion elephant in the room. They closed that deal in late March. Clario is a digital endpoint data solutions company that complements their clinical research business. Even though it was only in the results for a few days, it contributed $30 million in revenue and a penny per share to Q1.

ALEX: And CEO Marc Casper was pretty excited about it on the call. He kept talking about how it enhances their "trusted partner status" with pharma and biotech customers. The integration seems to be going smoothly, and customers are apparently enthusiastic about combining Thermo's capabilities with Clario's digital endpoints technology.

JORDAN: Speaking of pharma and biotech, that was actually their strongest end market in the quarter with mid-single digit growth. Casper highlighted strength in bioproduction and clinical research. But let's talk about the headwinds they're facing.

ALEX: Yeah, this is where it gets interesting. They had some real operational challenges. First, they had one less selling day compared to last year, which dinged organic growth by about a percentage point. Then there was revenue phasing in pharma services - another roughly one-point headwind.

JORDAN: So if you normalize for those factors, their 1% organic growth in Q1 would have been closer to 3%. And that's exactly what they're guiding for in Q2. The concern from analysts on the call was about this acceleration they need in the back half of the year to hit their full-year 3-4% organic growth target.

ALEX: Casper seemed pretty confident though. He said the markets are playing out exactly as expected, and the ramp isn't really assuming any change in underlying market conditions. It's more about these timing issues and comparisons normalizing.

JORDAN: Let's break down the segments because there were some real divergences. Life Sciences Solutions was the star with 13% reported growth, though only 1% organic. That was driven by their bioproduction business having "another quarter of excellent organic growth," as CFO Stephen Williamson put it.

ALEX: Meanwhile, Analytical Instruments was flat on revenue with organic declining 2%. This is the ongoing story we've been hearing across the industry - weak academic and government spending, especially in the US and China. Margins in that segment got hit hard, down 250 basis points to 20.7%.

JORDAN: Ouc

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Thermo Fisher just delivered some really solid numbers to cap off 2025, plus they dropped a massive $9 billion acquisition announcement. There's a lot to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Q4 revenue came in at $12.21 billion, up 7% year-over-year. For the full year, they hit $44.56 billion in revenue, growing 4%. But here's what I found interesting - their adjusted EPS grew 8% in the quarter to $6.57, and 5% for the full year to $22.87.

**JORDAN:** That EPS growth is noteworthy because it shows they're managing their operations really well despite some headwinds. CEO Marc Casper mentioned they faced over 100 basis points of margin pressure from tariffs and foreign exchange impacts. Yet they still delivered solid earnings growth - that's the power of their PPI business system at work.

**ALEX:** Speaking of headwinds, let's talk about how different end markets performed. Pharma and biotech was the standout - high single-digit growth in Q4 and mid-single digits for the full year. That's their core market, so seeing strength there is crucial.

**JORDAN:** Right, and Casper gave some really interesting color on customer sentiment in pharma during the Q&A. He talked about meeting with pharma CEOs who were much more optimistic, saying the tone in January customer meetings was "quite positive." He even shared this great anecdote about a pharma CEO who was so engaged in their discussion that he literally went and found his head of development mid-conversation to dive deeper into specifics.

**ALEX:** That's the kind of customer relationship that's hard to quantify but incredibly valuable. It speaks to their "trusted partner" positioning. But not all end markets were as rosy - academic and government declined low single digits both for the quarter and full year, largely due to macro conditions in the US and China.

**JORDAN:** Yeah, and that's reflected in their 2026 guidance assumptions. They're basically planning for similar market conditions to 2025, which seems prudent. They're guiding for 3-4% organic growth and 4-6% reported revenue growth, targeting $46.3 to $47.2 billion in revenue.

**ALEX:** The earnings guidance is where things get interesting though. They're projecting 6-8% adjusted EPS growth, hitting $24.22 to $24.80 per share. That's pretty strong earnings leverage even with modest revenue growth.

**JORDAN:** Exactly, and that doesn't even include the potential impact from their big acquisition announcement - Clario. This is a $9 billion deal for a digital endpoint data provider that generated about $1.5 billion in 2025 revenue. If it closes by year-end as expected, it could add another $0.45 in adjusted EPS.

**ALEX:** Let's dig into that Clario deal because it's fascinating strategically. They're essentially buying capabilities in one of the fastest-growing areas of clinical research - digital endpoints for clinical trials. This fits perfectly with their "Accelerated Drug Development" solution that combines their pharma services and clinical research businesses.

**JORDAN:** And Casper was really enthusiastic about this during the call. He talked about how it will enable "even deeper clinical insights" and "further accelerate the digital transformation of clinical research." Plus, they ment

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH — TJX Companies (TJX) Q2 Fiscal 2027 Earnings Breakdown**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into TJX Companies — the parent of TJ Maxx, Marshalls, HomeGoods, and Sierra — and their second quarter fiscal 2027 results.

ALEX: Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good to have that out of the way. So, Alex, headline number first — how'd they do?

ALEX: Pretty strong quarter overall. Consolidated comp sales up 4%, which beat their own plan. Adjusted diluted EPS came in at $1.22, up 11% year-over-year, and also well above what they'd guided to. Off the back of that, they actually raised full-year guidance — now looking at $5.15 to $5.20 in adjusted EPS for the year, up 9-10% from last year.

JORDAN: That's a solid beat-and-raise. But there was one wrinkle in there — Marmaxx, which is their biggest division by far, TJ Maxx and Marshalls combined, only grew comps 1%. Everybody else was humming.

ALEX: Right, and that's really the story of this call. HomeGoods put up a 7% comp, TJX Canada was up 6%, and TJX International — that's Europe and Australia — was up 7% as well. Those three carried the quarter while Marmaxx lagged.

JORDAN: CEO Ernie Herrman was pretty candid about what happened there. He called it "self-inflicted" — basically said they didn't have the right merchandise mix in the right stores at the right time. Not a demand problem, not a competitive pricing problem.

ALEX: Yeah, and he made a point of saying they actually checked — their comps near direct off-price competitors were basically identical to comps in stores without nearby competition. So this wasn't about getting out-priced by anyone. It was execution — certain categories where they just didn't have enough of the right inventory, so shoppers walked in and couldn't find what might've been an impulse buy.

JORDAN: What I found interesting is he framed the fix as already underway — said sales were improving into August, and he expects to be back to that normal 2-3% comp range for Marmaxx by the fourth quarter, in time for holiday.

ALEX: They also said they've built in some new systematic planning processes to catch this kind of mix issue earlier. And notably, everyone from buyers up to Herrman himself was looped into fixing it — so it sounds like this got serious internal attention.

JORDAN: Meanwhile, HomeGoods was the real standout. Let's talk about that — 7% comp, and adjusted segment profit margin jumped 240 basis points to 12.4%. That's a big move.

ALEX: Herrman was genuinely excited about that one. He talked about HomeGoods becoming this dual-purpose destination — not just the treasure-hunt impulse shopping people associate with it, but now also a place people go for everyday consumable staples, like replenishing kitchen or home goods regularly. That combination is driving really consistent traffic.

JORDAN: And on the margin side, CFO John Kirby noted it's a mix of the sales leverage from that strong comp, some operational efficiencies, and lower tariff costs boosting merchandise margin.

ALEX: Speaking of tariffs — that's a thread running through this whole call. TJX actually received tariff refunds during the quarter, and all the numbers we're discussing are on an adjusted basis that strips those out, along with some related compensation accruals tied to them.

JORDAN: Worth flagging for listeners — gross margin was up 70 basis points to 31.4% in the quarter, largely tariff-driven favorability. But looking into the back half, management guided gross margin roughly flat to slightly down

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**Beta Finch Podcast Script: TJX Companies Q1 2027 Earnings**

---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into TJX Companies' first quarter 2027 results - and wow, what a quarter for the off-price retail giant.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, TJX just delivered some seriously impressive numbers. Walk us through the headline figures.

**ALEX:** The numbers are genuinely eye-popping, Jordan. TJX posted earnings per share of $1.19, up 29% year-over-year and well above expectations. But here's what really caught my attention - they achieved a 6% comparable sales increase across the board. That's not just one division carrying the load; every single banner delivered strong comp growth.

**JORDAN:** That consistency is remarkable. And it wasn't just top-line growth, right? Their pretax profit margin hit 12.0%, up 170 basis points. Gross margin expanded 180 basis points to 31.3%. These are the kind of margin expansions that make investors sit up and take notice.

**ALEX:** Exactly. And get this - CEO Ernie Herrman said this performance was so strong that they're raising full-year guidance. They bumped consolidated sales guidance to $63.2 to $63.7 billion, and increased earnings per share guidance to $5.08 to $5.15. When's the last time you saw a company raise full-year guidance in their first quarter?

**JORDAN:** That's confidence right there. Let's break down what's driving this performance. The comp sales growth was split equally between higher average basket and increased customer transactions. So they're getting more people through the doors AND those people are spending more per visit.

**ALEX:** The geographic spread is fascinating too. Marmaxx in the US delivered 6% comp growth, but HomeGoods absolutely crushed it with 9% comp growth. Even their international segments performed well - Canada up 7%, international up 4%.

**JORDAN:** I love what Herrman said about their buying power in this environment. He mentioned they have over 1,400 buyers in the marketplace, and with economic uncertainty, they're often the "first call" for vendors looking to clear inventory. It's like TJX is built for these kinds of challenging retail environments.

**ALEX:** That's a great point. There was an interesting exchange during the Q&A about customer behavior. An analyst asked if customers were trading down or avoiding higher-priced items, but management pushed back, saying they're not seeing any change in purchasing patterns across income demographics.

**JORDAN:** Which suggests their "good, better, best" strategy is really working. They're capturing customers across all income levels. Herrman also mentioned something intriguing about new customer acquisition - they're seeing a "disproportionately younger age group" of new customers, particularly Gen Z and millennials.

**ALEX:** That's huge for long-term growth. Speaking of long-term, they just opened their first store in Spain, and management sounds very bullish about international expansion opportunities. They mentioned potentially revisiting their long-term store count targets.

**JORDAN:** The fuel situation is worth noting too. CFO John Klinger explained that they benefited from fuel hedges in Q1, but they're assuming current diesel prices remain elevated for the rest of the year. If fuel prices drop, that could be upside to profitability.

**ALEX:** There was also a subtle but important comment about inventory levels being up 8%. Normally that might concern investors, but in TJX

This episode includes AI-generated content.